CTOs on the Move

ZERO - The End of Prostate Cancer

www.zerocancer.org

 
ZERO - The End of Prostate Cancer is a 501 non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Amcare Medical Systems d/b/a Amcare Ambulance Service

Amcare Medical Systems d/b/a Amcare Ambulance Service is a Saint Albans, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wellstart International Inc

Wellstart International Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PathWell

PathWell Health is a Medicare certified home healthcare agency that offers skilled nursing and therapy services to help patients maintain independence and quality of life in the comfort of their own homes.

Q S Pharma

Q S Pharma LLC is a Marcus Hook, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.